Galapagos | GLPG - Ordinary Share Capital

Stock Price
29.86
Daily Change
1.46 5.14%
Monthly
3.18%
Yearly
18.49%
Q1 Forecast
27.85

Galapagos reported EUR65.9M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
AstraZeneca USD 1.55B 206K Dec/2025
Biogen USD 146.7M 200K Sep/2025
Genmab DKK 10M 56M Mar/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
GRIFOLS EUR 679.73M 0 Sep/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Incyte USD 198.46M 2.33M Dec/2025
Merck EUR 434.78M 130.22M Jun/2025
Neurocrine Biosciences USD 100.1M 400K Dec/2025
Novartis USD 1.94B 23.4M Jun/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
UCB EUR 584M 0 Dec/2024
Vertex Pharmaceuticals USD 254M 0 Dec/2025